MMP9 and neoplasm: Evidence has shown that the levels of matrix metalloproteinase (MMP)9, vascular endothelial growth factor A (VEGFA), and CCL8 are all increased in tumor monocytes, with CCL8 showing the most pronounced upregulation compared to non-tumor monocytes.